Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

The iLet Bionic Pancreas is currently the closest automated insulin delivery system to a fully closed loop system. At ADA's 82nd Scientific Sessions, a panel of experts...
The American Diabetes Association's 82nd Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the...
Mounjaro (tirzepatide), a first-of-its kind medication for treating type 2 diabetes, has been approved by the FDA after much anticipation. This new medication has been...
Learn what some of the latest research says about the heart health benefits of diabetes drugs like SGLT-2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs.
At ATTD 2022, researchers discussed the latest research on pregnancy, menstrual cycles, and overall health outcomes in women with diabetes. Diabetes technology can be a...
Automated insulin delivery systems are becoming more advanced and over time have become more widely adopted within the diabetes community. At ATTD 2022, experts...
In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.
Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies.
At ATTD 2022, several researchers presented on projects aimed at understanding and addressing the impact of hypoglycemia. While diabetes technology is helpful and...
The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top...
How might exercise affect your blood glucose? The T1-DEXI study hopes to answer this big question with real-world data from over 600 people with type 1 diabetes –...
Learn more about how you can participate in this clinical trial from Novo Nordisk, testing whether a new once-weekly insulin injection, when combined with semaglutide,...
The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...
Metformin is the world’s most common diabetes medication and can improve diabetes management. Research suggests that metformin might lead to weight loss in certain...
Fractyl Health has developed a new technology called duodenal mucosal resurfacing, which can "reset" your gut, leading to improvements in glucose levels and weight and a...
Time in Range (TIR) is a well established and easy to use measurement of your daily glucose management. The glycemia risk index (or dysglycemia index) is an emerging...
Early trial results found that SGLT-2 inhibitor Jardiance is highly effective at preventing and treating kidney disease in people with or without type 2 diabetes.
The microbiome is an exciting area of research for diabetes management. What do we know and what questions do we still have about the microbiome?
People with diabetes who are also a part of the LGBTQ community face unique challenges when it comes to healthcare, dealing with stigma and body image issues. Shawn Laib...

Pages